Characteristics and Outcomes of Kidney Transplant Recipients with a Functioning Graft for More than 25 Years
- PMID: 30574502
- PMCID: PMC6276752
- DOI: 10.1159/000491575
Characteristics and Outcomes of Kidney Transplant Recipients with a Functioning Graft for More than 25 Years
Abstract
Background: Information regarding the clinical characteristics and outcomes of kidney transplant recipients (KTRs) with > 25 years of graft survival is limited.
Methods: In this single-center observational study, we characterized KTRs transplanted between 1973 and 1992 with active follow-up as of July 31, 2017.
Results: We identified 112 patients with > 25 years of allograft function. The mean posttransplantation follow-up was 29.8 ± 4.0 years. Glomerulonephritis was the most common cause of end-stage renal disease (ESRD) (52%). The majority received live donor transplants (66%), including 25 patients (22%) with human leukocyte antigen-matched kidneys. The incidence of biopsy-confirmed acute rejection was 21%, ranging from 0 to 26 years post transplantation. Donor-specific antibodies (DSA) were checked in 80% of patients at a mean of 28.4 ± 0.11 years post transplantation. Of these, only 15% were positive. The incidence of malignancy was 44%, with nonmelanoma skin cancers being most common. The incidence of infectious complications was 77%, mostly represented by urinary tract infections. At the time of last follow-up, 63% were on a calcineurin inhibitor (CNI)-free regimen, mean serum creatinine was 1.4 ± 0.6 mg/dL, and the prevalence of hypertension and dyslipidemia was 89 and 88%, respectively.
Conclusion: The majority of patients with a long-term functioning graft had glomerulonephritis as cause of ESRD, had received a live donor kidney, were on a CNI-free regimen, and had a low incidence of DSA and opportunistic infections. These characteristics define a unique group of patients requiring specific posttransplantation monitoring and management.
Keywords: Cardiovascular disease; Complications; Infections; Kidney transplant; Malignancy; Survival.
Figures
Similar articles
-
Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.Transplantation. 2000 Dec 27;70(12):1728-36. doi: 10.1097/00007890-200012270-00012. Transplantation. 2000. PMID: 11152105
-
Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.Transpl Immunol. 2008 Nov;20(1-2):32-42. doi: 10.1016/j.trim.2008.08.005. Epub 2008 Sep 4. Transpl Immunol. 2008. PMID: 18773960 Clinical Trial.
-
Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.Hum Immunol. 2020 Jul;81(7):323-329. doi: 10.1016/j.humimm.2020.04.002. Epub 2020 Apr 21. Hum Immunol. 2020. PMID: 32327243
-
Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview.Paediatr Drugs. 2009;11(6):381-96. doi: 10.2165/11316100-000000000-00000. Paediatr Drugs. 2009. PMID: 19877724 Review.
-
Sirolimus use in recipients of expanded criteria donor kidneys.Drugs. 2008;68 Suppl 1:41-9. doi: 10.2165/00003495-200868001-00006. Drugs. 2008. PMID: 18442300 Review.
Cited by
-
More Than 25 Years of Pancreas Graft Survival After Simultaneous Pancreas and Kidney Transplantation: Experience From the World's Largest Series of Long-term Survivors.Transplantation. 2020 Jun;104(6):1287-1293. doi: 10.1097/TP.0000000000002960. Transplantation. 2020. PMID: 31568218 Free PMC article.
-
Single-Cell Transcriptomic Analysis of Peripheral Blood Reveals a Novel B-Cell Subset in Renal Allograft Recipients With Accommodation.Front Pharmacol. 2021 Sep 30;12:706580. doi: 10.3389/fphar.2021.706580. eCollection 2021. Front Pharmacol. 2021. PMID: 34658852 Free PMC article.
-
Risks of cardiovascular disease and cerebrovascular disease following kidney transplantation: A nationwide, population-based cohort study.Int J Med Sci. 2025 Apr 13;22(9):2237-2246. doi: 10.7150/ijms.108744. eCollection 2025. Int J Med Sci. 2025. PMID: 40303501 Free PMC article.
-
Predictor factor for worse outcomes in kidney transplant recipients infected with coronavirus disease 2019: A systematic review and meta-analysis.Transpl Immunol. 2023 Feb;76:101739. doi: 10.1016/j.trim.2022.101739. Epub 2022 Nov 19. Transpl Immunol. 2023. PMID: 36414181 Free PMC article.
-
Entering the Third Decade After Kidney Transplantation: Excellent Graft Function Refers to Superior Graft but Not Patient Survival.Transpl Int. 2022 Oct 31;35:10675. doi: 10.3389/ti.2022.10675. eCollection 2022. Transpl Int. 2022. PMID: 36388427 Free PMC article.
References
-
- Pesavento TE. Kidney transplantation in the context of renal replacement therapy. Clin J Am Soc Nephrol. 2009;4:2035–2039. - PubMed
-
- Parajuli S, Clark DF, Djamali A. Is kidney transplantation a better state of CKD? Impact on diagnosis and management. Adv Chronic Kidney Dis. 2016;23:287–294. - PubMed
-
- Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2011;11:450–462. - PubMed
-
- Marcen R, Teruel JL. Patient outcomes after kidney allograft loss. Transplant Rev (Orlando) 2008;22:62–72. - PubMed
LinkOut - more resources
Full Text Sources